Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate

Hoigne syndrome (HS) is the term coined to describe an acute, non-allergic, psychiatrically based reaction occurring with a wide list of medications, mainly antibiotics. Since its first description by Hoigne and Schoch in 1959, few cases have been reported in medical literature and, although antimic...

Full description

Saved in:
Bibliographic Details
Published inOpen access Macedonian journal of medical sciences Vol. 5; no. 4; pp. 483 - 485
Main Authors Guarneri, Claudio, Tchernev, Georgi, Wollina, Uwe, Lotti, Torello
Format Journal Article
LanguageEnglish
Published North Macedonia ID Design 2012/DOOEL Skopje 25.07.2017
Subjects
Case Report
meglumine antimoniate
leishmaniasis
adverse drug reaction
Hoigne syndrome
injection
Online AccessGet full text
ISSN1857-9655
1857-9655
DOI10.3889/oamjms.2017.136

Cover

More Information
Summary:Hoigne syndrome (HS) is the term coined to describe an acute, non-allergic, psychiatrically based reaction occurring with a wide list of medications, mainly antibiotics. Since its first description by Hoigne and Schoch in 1959, few cases have been reported in medical literature and, although antimicrobials are commonly used, very rarely in dermatology. The authors describe the first case occurred after intralesional administration of meglumine antimoniate and briefly discuss the pathogenetic hypotheses on this atypical adverse drug reaction.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1857-9655
1857-9655
DOI:10.3889/oamjms.2017.136